retatrutide inflammation Side Effects: What Patients Should Know This isn’t just about weight

Doctors have at times been accomplices by recklessly offering prescriptions for these medications with minimal or no patient assessment and support

Review the sources used below for this article: This article references information from a study published in the BMJ: Risk of hair loss associated with glucagon-like peptide-1 receptor agonists in adults with type 2 diabetes: target trial emulation

Abstract Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes mellitus (T2DM)

Individual results, side effects, eligibility, and long-term outcomes vary

Researchers attribute this to dopamine dysregulation, nutrient deficiencies, and hormone imbalances

NPJ Aging Mech Dis